Literature DB >> 33793335

Oxidative Stress and Hypertension.

Kathy K Griendling1, Livia L Camargo2, Francisco J Rios2, Rhéure Alves-Lopes2, Augusto C Montezano2, Rhian M Touyz2.   

Abstract

A link between oxidative stress and hypertension has been firmly established in multiple animal models of hypertension but remains elusive in humans. While initial studies focused on inactivation of nitric oxide by superoxide, our understanding of relevant reactive oxygen species (superoxide, hydrogen peroxide, and peroxynitrite) and how they modify complex signaling pathways to promote hypertension has expanded significantly. In this review, we summarize recent advances in delineating the primary and secondary sources of reactive oxygen species (nicotinamide adenine dinucleotide phosphate oxidases, uncoupled endothelial nitric oxide synthase, endoplasmic reticulum, and mitochondria), the posttranslational oxidative modifications they induce on protein targets important for redox signaling, their interplay with endogenous antioxidant systems, and the role of inflammasome activation and endoplasmic reticular stress in the development of hypertension. We highlight how oxidative stress in different organ systems contributes to hypertension, describe new animal models that have clarified the importance of specific proteins, and discuss clinical studies that shed light on how these processes and pathways are altered in human hypertension. Finally, we focus on the promise of redox proteomics and systems biology to help us fully understand the relationship between ROS and hypertension and their potential for designing and evaluating novel antihypertensive therapies.

Entities:  

Keywords:  antioxidants; biomarkers; endoplasmic reticulum stress; hydrogen peroxide; reactive oxygen species

Mesh:

Substances:

Year:  2021        PMID: 33793335      PMCID: PMC8293920          DOI: 10.1161/CIRCRESAHA.121.318063

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  336 in total

1.  Nicotinamide adenine dinucleotide phosphate reduced oxidase 5 (Nox5) regulation by angiotensin II and endothelin-1 is mediated via calcium/calmodulin-dependent, rac-1-independent pathways in human endothelial cells.

Authors:  Augusto C Montezano; Dylan Burger; Tamara M Paravicini; Andreia Z Chignalia; Hiba Yusuf; Mahmoud Almasri; Ying He; Glaucia E Callera; Gang He; Karl-Heinz Krause; David Lambeth; Mark T Quinn; Rhian M Touyz
Journal:  Circ Res       Date:  2010-03-25       Impact factor: 17.367

2.  NOX5 variants are functionally active in endothelial cells.

Authors:  Rachida S BelAiba; Talija Djordjevic; Andreas Petry; Kerstin Diemer; Steve Bonello; Botond Banfi; John Hess; Alexej Pogrebniak; Christian Bickel; Agnes Görlach
Journal:  Free Radic Biol Med       Date:  2006-11-03       Impact factor: 7.376

Review 3.  Differential impacts of brain stem oxidative stress and nitrosative stress on sympathetic vasomotor tone.

Authors:  Julie Y H Chan; Samuel H H Chan
Journal:  Pharmacol Ther       Date:  2019-05-31       Impact factor: 12.310

4.  Attenuating endoplasmic reticulum stress as a novel therapeutic strategy in pulmonary hypertension.

Authors:  Peter Dromparis; Roxane Paulin; Trevor H Stenson; Alois Haromy; Gopinath Sutendra; Evangelos D Michelakis
Journal:  Circulation       Date:  2012-11-13       Impact factor: 29.690

5.  Catalase overexpression prevents hypertension and tubular apoptosis in angiotensinogen transgenic mice.

Authors:  Nicolas Godin; Fang Liu; Garnet J Lau; Marie-Luise Brezniceanu; Isabelle Chénier; Janos G Filep; Julie R Ingelfinger; Shao-Ling Zhang; John S D Chan
Journal:  Kidney Int       Date:  2010-03-17       Impact factor: 10.612

Review 6.  Redox regulation of mitochondrial ATP synthase.

Authors:  Sheng-Bing Wang; Christopher I Murray; Heaseung S Chung; Jennifer E Van Eyk
Journal:  Trends Cardiovasc Med       Date:  2013-01       Impact factor: 6.677

7.  Mitochondria-targeted antioxidant MitoQ10 improves endothelial function and attenuates cardiac hypertrophy.

Authors:  Delyth Graham; Ngan N Huynh; Carlene A Hamilton; Elisabeth Beattie; Robin A J Smith; Helena M Cochemé; Michael P Murphy; Anna F Dominiczak
Journal:  Hypertension       Date:  2009-07-06       Impact factor: 10.190

Review 8.  New Therapeutic Implications of Endothelial Nitric Oxide Synthase (eNOS) Function/Dysfunction in Cardiovascular Disease.

Authors:  Andreas Daiber; Ning Xia; Sebastian Steven; Matthias Oelze; Alina Hanf; Swenja Kröller-Schön; Thomas Münzel; Huige Li
Journal:  Int J Mol Sci       Date:  2019-01-07       Impact factor: 5.923

9.  A pivotal role for tryptophan 447 in enzymatic coupling of human endothelial nitric oxide synthase (eNOS): effects on tetrahydrobiopterin-dependent catalysis and eNOS dimerization.

Authors:  Matthew A Benson; Helen Batchelor; Surawee Chuaiphichai; Jade Bailey; Hanneng Zhu; Dennis J Stuehr; Shoumo Bhattacharya; Keith M Channon; Mark J Crabtree
Journal:  J Biol Chem       Date:  2013-08-21       Impact factor: 5.157

10.  Sirtuin 3 is essential for hypertension-induced cardiac fibrosis via mediating pericyte transition.

Authors:  Han Su; Heng Zeng; Bo Liu; Jian-Xiong Chen
Journal:  J Cell Mol Med       Date:  2020-05-28       Impact factor: 5.310

View more
  24 in total

1.  Forestalling age-impaired angiogenesis and blood flow by targeting NOX: Interplay of NOX1, IL-6, and SASP in propagating cell senescence.

Authors:  Yao Li; Damir Kračun; Christopher M Dustin; Mohamed El Massry; Shuai Yuan; Christian J Goossen; Evan R DeVallance; Sanghamitra Sahoo; Cynthia St Hilaire; Aditi U Gurkar; Toren Finkel; Adam C Straub; Eugenia Cifuentes-Pagano; Patrick J Pagano
Journal:  Proc Natl Acad Sci U S A       Date:  2021-10-19       Impact factor: 11.205

2.  Identification of Metabolic Syndrome-Related miRNA-mRNA Regulatory Networks and Key Genes Based on Bioinformatics Analysis.

Authors:  Lingyan Qiu; Pei Sheng; Xu Wang
Journal:  Biochem Genet       Date:  2022-07-25       Impact factor: 2.220

Review 3.  Cardiovascular risk in patients receiving antihypertensive drug treatment from the perspective of endothelial function.

Authors:  Tatsuya Maruhashi; Yukihito Higashi
Journal:  Hypertens Res       Date:  2022-05-20       Impact factor: 5.528

4.  The association between Alu hypomethylation and the severity of hypertension.

Authors:  Jirapan Thongsroy; Apiwat Mutirangura
Journal:  PLoS One       Date:  2022-07-08       Impact factor: 3.752

Review 5.  New Progress in the Molecular Regulations and Therapeutic Applications in Cardiac Oxidative Damage Caused by Pressure Overload.

Authors:  Xiaomeng Shi; Arin Dorsey; Hongyu Qiu
Journal:  Antioxidants (Basel)       Date:  2022-04-29

Review 6.  Mechanisms and clinical implications of endothelium-dependent vasomotor dysfunction in coronary microvasculature.

Authors:  Sharif A Sabe; Jun Feng; Frank W Sellke; M Ruhul Abid
Journal:  Am J Physiol Heart Circ Physiol       Date:  2022-03-25       Impact factor: 5.125

7.  Fetal Undernutrition Modifies Vascular RAS Balance Enhancing Oxidative Damage and Contributing to Remodeling.

Authors:  Maria Sofia Vieira-Rocha; Pilar Rodriguez-Rodriguez; Mariana Ferreira-Duarte; Miguel Faria; Joana Beatriz Sousa; Manuela Morato; Silvia Magdalena Arribas; Carmen Diniz
Journal:  Int J Mol Sci       Date:  2022-01-22       Impact factor: 5.923

Review 8.  Programming of Vascular Dysfunction by Maternal Stress: Immune System Implications.

Authors:  Tiago J Costa; Júlio Cezar De Oliveira; Fernanda Regina Giachini; Victor Vitorino Lima; Rita C Tostes; Gisele Facholi Bomfim
Journal:  Front Physiol       Date:  2022-03-10       Impact factor: 4.566

9.  Recent findings on the cellular and molecular mechanisms of action of novel food-derived antihypertensive peptides.

Authors:  Innocent U Okagu; Timothy P C Ezeorba; Emmanuel C Aham; Rita N Aguchem; Regina N Nechi
Journal:  Food Chem (Oxf)       Date:  2022-01-25

Review 10.  Oxidative Stress in Arterial Hypertension (HTN): The Nuclear Factor Erythroid Factor 2-Related Factor 2 (Nrf2) Pathway, Implications and Future Perspectives.

Authors:  Daniela Maria Tanase; Alina Georgiana Apostol; Claudia Florida Costea; Claudia Cristina Tarniceriu; Ionut Tudorancea; Minela Aida Maranduca; Mariana Floria; Ionela Lacramioara Serban
Journal:  Pharmaceutics       Date:  2022-02-27       Impact factor: 6.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.